CHRNA7 and Anxiety: Clinically, the α7-nAChR negative allosteric modulator, BNC210, has been shown to reduce self-reported anxiety (STAI) in individuals with GAD (Perkins et al., 2021) and decrease amygdala responses to threat (fearful faces) (Wise et al., 2020).